# Chemed Corp: Form 10-Q for the period ended Jun 30, 2014

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-Q
- Filed: 2014-07-30
- Accepted by EDGAR: Jul 30, 2014, 08:20 ET
- Period: 2014-06-30
- Accession: 0001157523-14-003093
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000115752314003093/a50912165.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000115752314003093/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-04-01 to 2014-06-30 | $360.2m | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2014-01-01 to 2014-06-30 | $718.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2014-04-01 to 2014-06-30 | $257.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2014-01-01 to 2014-06-30 | $514.8m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2014-04-01 to 2014-06-30 | $53.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2014-01-01 to 2014-06-30 | $109.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-04-01 to 2014-06-30 | $41.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2014-01-01 to 2014-06-30 | $78.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-04-01 to 2014-06-30 | $2.4m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2014-01-01 to 2014-06-30 | $6.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-04-01 to 2014-06-30 | $15.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2014-01-01 to 2014-06-30 | $28.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-04-01 to 2014-06-30 | $24.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2014-01-01 to 2014-06-30 | $44.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-04-01 to 2014-06-30 | $1.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2014-01-01 to 2014-06-30 | $2.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-04-01 to 2014-06-30 | $1.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2014-01-01 to 2014-06-30 | $2.59 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-04-01 to 2014-06-30 | 17,880,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2014-01-01 to 2014-06-30 | 18,097,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2014-01-01 to 2014-06-30 | $45.1m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2014-01-01 to 2014-06-30 | $19.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2014-01-01 to 2014-06-30 | $6.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2014-01-01 to 2014-06-30 | $58.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-06-30 | $27.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-06-30 | $165.5m | us-gaap:AssetsCurrent |
| Total assets | at 2014-06-30 | $841.6m | us-gaap:Assets |
| Current liabilities | at 2014-06-30 | $156.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-06-30 | $397.1m | us-gaap:Liabilities |
| Long-term debt | at 2014-06-30 | $155.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-06-30 | $5.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2014-06-30 | $444.5m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2014-06-30 | 17,287,284 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000115752314003093/a50912165.htm

Filed Jul 30, 2014.
Source: SEC EDGAR, the filing index for accession 0001157523-14-003093. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
